2 registrations that name saffron as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
All 2 registrations
RecruitingNCT07497698
Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults
No phase
Universidad de Granada
About 80 people
Started Mar 1, 2026
In plain words A study of saffron in people 18 to 65, run by Universidad de Granada. It plans to enroll about 80 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 65; healthy volunteers accepted. Conditions: Sleep.
Age 18-65 years
Mild-to-moderate sleep disturbances
BMI between 18 and 35 kg/m²
Not receiving active pharmacological or psychological treatment for sleep disorders
1 more inclusion criterion and the exclusion criteria are on the listing.
What it tests, as registered
Saffron Extract; Dietary Supplement: Placebo
Registered summary
This randomized, triple-blind, placebo-controlled clinical trial aims to evaluate the effects of daily saffron extract supplementation (30 mg/day) for six weeks on objective and subjective sleep quality in middle-aged adults with mild-to-moderate sleep disturbances. Secondary outcomes include heart rate variability, cognitive processing speed, emotional state, perceived health status, and biochemical stress markers.
Where, as registered
No US site; Spain (1).
Not yet recruitingNCT07324759
Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects.
No phase
NovoBliss Research Pvt Ltd
About 50 people
Starts Jan 1, 2026 (estimated)
In plain words A study of saffron in people 30 to 55, run by NovoBliss Research Pvt Ltd. It plans to enroll about 50 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists people 30 to 55; healthy volunteers accepted. Conditions: Wrinkles; Fine Lines; Hyperpigmentation; Dark Spots.
Age: 30 to 55 years (both inclusive) at the time of consent.
Sex: Adult male and female having wrinkles and fine lines at crow feet's area, facial hyperpigmentation and dark spots such as tan, pimple marks, sunspots, age spots, uneven skin tone on both side of face.
Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit.
Subjects should not have used any cosmetic, nutraceutical or therapeutic products for skin ageing in last 1 month.
5 more inclusion criteria and the exclusion criteria are on the listing.
This is a randomized, double-blind, comparative, two-arm, prospective, interventional, multi-centre clinical study to evaluate the safety, efficacy, and in-use tolerability of test products, standardized saffron extract capsules, on skin rejuvenation and age-defying benefits in healthy adult male and female subjects.